Journal
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Volume 11, Issue 6, Pages 603-609Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920110792246573
Keywords
Phage display; molecular imaging; tumor; peptide; antibody
Funding
- NSFC [30670741, 30870728, 20820102035, 30930030, 30900373]
- 863 project [2007AA02Z467]
- Ministry of Science and Technology of China [2009ZX09103-733, 2009ZX09103-746, 2009ZX09301-010]
Ask authors/readers for more resources
The advancement of molecular imaging hardware and disease targets has driven the demand of novel probes for diagnosis of human diseases. The high-throughput property of phage-display techniques makes the fast developments of these probes possible. The antibody and peptide phage display libraries have been widely used in ligand-selections for a variety of targets in tumors including osteosarcomas, pancreatic ductal adenocarcinomas, thyroid, head and neck squamous cell carcinomas, prostate, bladder, colon and gastric cancers. The phage display techniques also have been utilized in development of imaging agents for tumor therapy response, apoptosis, hypoxia, infection and inflammation, Alzheimer's diseases, diabetes and cardiovascular diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available